These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31114684)

  • 1. Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells.
    Sala L; Gnecchi M; Schwartz PJ
    Arrhythm Electrophysiol Rev; 2019 May; 8(2):105-110. PubMed ID: 31114684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Duncan G; Firth K; George V; Hoang MD; Staniforth A; Smith G; Denning C
    Stem Cells Dev; 2017 Dec; 26(23):1695-1705. PubMed ID: 28992755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Rocchetti M; Sala L; Dreizehnter L; Crotti L; Sinnecker D; Mura M; Pane LS; Altomare C; Torre E; Mostacciuolo G; Severi S; Porta A; De Ferrari GM; George AL; Schwartz PJ; Gnecchi M; Moretti A; Zaza A
    Cardiovasc Res; 2017 Apr; 113(5):531-541. PubMed ID: 28158429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation.
    Yamamoto Y; Makiyama T; Harita T; Sasaki K; Wuriyanghai Y; Hayano M; Nishiuchi S; Kohjitani H; Hirose S; Chen J; Yokoi F; Ishikawa T; Ohno S; Chonabayashi K; Motomura H; Yoshida Y; Horie M; Makita N; Kimura T
    Hum Mol Genet; 2017 May; 26(9):1670-1677. PubMed ID: 28335032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.
    Sala L; Yu Z; Ward-van Oostwaard D; van Veldhoven JP; Moretti A; Laugwitz KL; Mummery CL; IJzerman AP; Bellin M
    EMBO Mol Med; 2016 Sep; 8(9):1065-81. PubMed ID: 27470144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.
    Devalla HD; Gélinas R; Aburawi EH; Beqqali A; Goyette P; Freund C; Chaix MA; Tadros R; Jiang H; Le Béchec A; Monshouwer-Kloots JJ; Zwetsloot T; Kosmidis G; Latour F; Alikashani A; Hoekstra M; Schlaepfer J; Mummery CL; Stevenson B; Kutalik Z; de Vries AA; Rivard L; Wilde AA; Talajic M; Verkerk AO; Al-Gazali L; Rioux JD; Bhuiyan ZA; Passier R
    EMBO Mol Med; 2016 Dec; 8(12):1390-1408. PubMed ID: 27861123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Song Y; Zheng Z; Lian J
    Front Cardiovasc Med; 2022; 9():889519. PubMed ID: 35647048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
    Paci M; Casini S; Bellin M; Hyttinen J; Severi S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long-QT Syndrome.
    Limpitikul WB; Dick IE; Tester DJ; Boczek NJ; Limphong P; Yang W; Choi MH; Babich J; DiSilvestre D; Kanter RJ; Tomaselli GF; Ackerman MJ; Yue DT
    Circ Res; 2017 Jan; 120(1):39-48. PubMed ID: 27765793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
    Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
    Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
    J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.
    Malan D; Friedrichs S; Fleischmann BK; Sasse P
    Circ Res; 2011 Sep; 109(8):841-7. PubMed ID: 21799153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes.
    Kuusela J; Kujala VJ; Kiviaho A; Ojala M; Swan H; Kontula K; Aalto-Setälä K
    Springerplus; 2016; 5():234. PubMed ID: 27026928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low extracellular potassium prolongs repolarization and evokes early afterdepolarization in human induced pluripotent stem cell-derived cardiomyocytes.
    Kuusela J; Larsson K; Shah D; Prajapati C; Aalto-Setälä K
    Biol Open; 2017 Jun; 6(6):777-784. PubMed ID: 28619993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New iPSC for old long QT syndrome modeling: putting the evidence into perspective.
    Li G; Cheng G; Wu J; Ma S; Sun C
    Exp Biol Med (Maywood); 2014 Feb; 239(2):131-40. PubMed ID: 24363251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
    Friedrichs S; Malan D; Sasse P
    Trends Cardiovasc Med; 2013 May; 23(4):91-8. PubMed ID: 23266156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.